The Patent Finder

Corvivo Cardiovascular, Inc.

77 patents currently held · Updated Nov 21, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
26
Ending by 2030
May 2027
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 2 fees due Dec 2 to 23, 2026 · next Dec 2
  • 2 fees due Jan 21 to 28, 2027 · next Jan 21
  • 1 fee due Feb 20, 2027
    The maintenance fee for Cardiovascular Prostheses (US 10,383,977) comes due Feb 20, 2027. Unpaid by Aug 20, 2027, it lapses early.
  • 1 fee due Mar 1, 2027
    The maintenance fee for Compositions and Methods for Preventing Cardiac Arrhythmia (US 9,119,841) comes due Mar 1, 2027. Unpaid by Sep 1, 2027, it lapses early.
  • 1 fee due Jun 24, 2027
    The maintenance fee for Cardiovascular Prostheses (US 10,512,710) comes due Jun 24, 2027. Unpaid by Dec 27, 2027, it lapses early.
  • 3 fees due Jul 5 to 26, 2027 · next Jul 5
  • 1 fee due Aug 20, 2027
    The maintenance fee for Prosthetic Venous Valves (US 11,903,833) comes due Aug 20, 2027. Unpaid by Feb 22, 2028, it lapses early.
  • 2 fees due Oct 12 to 30, 2027 · next Oct 12

Which patents, and when each one lapses · Pro

Recent changes

  • 1 term has ended since Aug 23, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,149,496ECM Constructs for Treating Damaged Biological Tissue
In force
 · High confidence
In forceHigh confidence
US 9,610,149Extracellular Matrix Constructs for Treating Damaged Biological Tissue
In force
 · High confidence
In forceHigh confidence
US 10,512,711Articles for Tissue Regeneration with Biodegradable Polymer
In force
 · High confidence
In forceHigh confidence
US 9,642,692Extracellular Matrix Constructs for Treating Damaged Biological Tissue
In force
 · High confidence
In forceHigh confidence
US D688,372Prosthetic Tissue Valve
In force
 · High confidence
In forceHigh confidence
US 9,700,654Extracellular Matrix (ECM) Structures for Tissue Regeneration
In force
 · High confidence
In forceHigh confidence
US D694,408Prosthetic Tissue Valve
In force
 · High confidence
In forceHigh confidence
US 8,409,275Prosthetic Tissue Valve
In force
 · High confidence
In forceHigh confidence
US 8,449,607Prosthetic Tissue Valve
In force
 · High confidence
In forceHigh confidence
US 8,608,796Prosthetic Tissue Valve
In force
 · High confidence
In forceHigh confidence
10 of 77 patents shown.
Pro members see all 77.
Pro members: see all 77 patents
Also on record, not counted in the 77: 31 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited